S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
S&P 500   3,026.81 (-2.87%)
DOW   26,169.69 (-2.92%)
QQQ   209.19 (-3.37%)
FB   192.16 (-2.56%)
MSFT   163.75 (-3.77%)
GOOGL   1,355.80 (-2.49%)
AMZN   1,914.19 (-3.30%)
CGC   18.13 (-8.53%)
NVDA   253.49 (-5.29%)
BABA   202.67 (-2.91%)
MU   50.28 (-3.99%)
GE   10.45 (-4.57%)
TSLA   679.16 (-12.79%)
AMD   42.22 (-11.10%)
T   35.91 (-3.21%)
ACB   1.36 (-10.56%)
F   6.97 (-3.33%)
NFLX   386.90 (+2.02%)
BAC   29.24 (-4.54%)
DIS   119.54 (-3.10%)
GILD   75.21 (+0.67%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MOTIF BIO PLC/SParnell PharmaceuticalsBoston TherapeuticsInnovus PharmaceuticalsAnthera Pharmaceuticals
SymbolNASDAQ:MTFBOTCMKTS:PARNFOTCMKTS:BTHEOTCMKTS:INNVDOTCMKTS:ANTH
Price Information
Current Price$0.11$0.11$0.03N/A$0.03
52 Week RangeBuyN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price Target$5.00N/AN/AN/AN/A
% Upside from Price Target4,661.90% upsideN/AN/AN/AN/A
Trade Information
Market Cap$1.56 million$1.83 million$2.50 million$2.90 million$772,000.00
Beta-0.322.880.222.894.28
Average VolumeN/A1,21418,99517,92485,619
Sales & Book Value
Annual RevenueN/A$14.67 million$30,000.00$23.99 millionN/A
Price / SalesN/A0.14100.020.00N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.60) per shareN/A($0.04) per share$0.05 per shareN/A
Price / BookN/A-0.680.00N/A
Profitability
Net Income$-13,980,000.00$-17,730,000.00$-3,600,000.00$-8,280,000.00$-26,870,000.00
EPS($0.07)N/AN/A($4.16)N/A
Trailing P/E RatioN/A0.000.00N/A0.00
Forward P/E RatioN/A0.00
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-14,864.27%-34.51%N/A
Return on Equity (ROE)N/AN/AN/A-682.54%N/A
Return on Assets (ROA)N/AN/A-307.96%-78.57%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio0.26%N/A0.05%0.68%N/A
Quick RatioN/AN/A0.05%0.36%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/A10.38%N/A
Insider Ownership PercentageN/AN/A15.65%16.43%2.08%
Miscellaneous
Employees7N/A212N/A
Shares Outstanding14.83 million18.02 million111.13 million2.36 million26.18 million
Next Earnings Date4/20/2020 (Estimated)4/3/2020 (Estimated)4/21/2020 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel